Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

N/A
Original languageEnglish
Pages (from-to)1193-1193-4; author reply 1194-5
JournalJournal of Antimicrobial Chemotherapy
Volume66
DOIs
Publication statusPublished - 2011

Keywords

  • Anti-Bacterial Agents
  • CD4-Positive T-Lymphocytes
  • Colon
  • Crohn Disease
  • Cytokines
  • Humans
  • Immunologic Factors
  • Lymphocyte Subsets
  • Metagenome
  • Models, Theoretical
  • Rifamycins

Fingerprint

Dive into the research topics of 'Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system'. Together they form a unique fingerprint.

Cite this